WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / February 2026 / K252714

510(k) cleared

C-Lant Port

Vigor Medical Technologies , Ltd. · Feb 27, 2026 · K252714

FDA cleared the C-Lant Port from Vigor Medical Technologies , Ltd. on Feb 27, 2026 under K252714, a traditional 510(k). The device falls under product code GCJ, Laparoscope, General & Plastic Surgery, regulated at 21 CFR 876.1500 as a Class 2 device. The review panel was Gastroenterology, Urology.

FDA logged the submission as received on Aug 27, 2025. The decision came 184 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Vigor Medical Technologies , Ltd. in the last 12 months of the tracker.

Questions & Answers

What did FDA clear under K252714?

K252714 is the FDA 510(k) for C-Lant Port, submitted by Vigor Medical Technologies , Ltd.. FDA's decision date was Feb 27, 2026, under product code GCJ (Laparoscope, General & Plastic Surgery).

Who makes the C-Lant Port?

Vigor Medical Technologies , Ltd., based in Haifa, is the applicant of record for K252714.

How long did the K252714 review take?

FDA received the submission on Aug 27, 2025 and issued its decision on Feb 27, 2026, 184 days later.

← All decisions in February 2026